RUBICON RESEARCH LIMITED

{
    "company_profile": "Rubicon Research Ltd is an India-based pharmaceutical formulations company, which is focused on research and development, with a portfolio of specialty products and drug-device combination products targeting regulated markets, and particularly the United States. Its portfolio spans multiple dosage forms, including oral solids, oral liquids, nasal, and topical. Its technologies include RubiReten and RubiSRL. Its services include intellectual property evaluation and product design, formulation research development, analytical research development, technology transfer, dossier compilation and regulatory support, and clinical trials supplies. Its products are spread across many therapeutic areas, such as Analgesics/Pain Management, CVS, CNS, Hypokalemia, Skeletal Muscle Relaxants, NRT, Gastrointestinal, Metabolic, Immunosuppressant, and others. Others include Antipyretic, Hormonal Products, Diuretic, Antimuscarinics, Oral Rehydration Therapy, Over the Counter products, and Respiratory.",
    "sector": "Pharmaceuticals",
    "sector_market_cap_inr": {
        "value": 26069.62,
        "unit": "crore",
        "formatted": "26,069.62 Cr"
    },
    "sector_market_cap_usd": {
        "value": 2.9,
        "unit": "billion",
        "formatted": "$2.90B"
    }
}